Clifford Chance advises Silom Medical Company on sale to Actavis
Clifford Chance has advised the owners of Silom Medical Company, Thailand's largest pharmaceutical company, on its sale to Actavis plc, a leading global specialty pharmaceutical company, for approximately US$100 million in cash. The acquisition propels Actavis into a top position in the Thai generic pharmaceutical market, with leading positions in the ophthalmic and respiratory therapeutic categories and a strong cardiovascular franchise.